or Try an Advanced Search...

    Intrexon Stocks List

    Symbol Grade Name % Change
    PGEN F Precigen, Inc. 10.91
    HALO F Halozyme Therapeutics, Inc. -0.81
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Life Sciences Antibodies Aquaculture Biological Engineering Biology Biopharmaceutical Cattle Clinical Trial Product Cloning Control Solutions Diabetes Diabetes Mellitus Emerging Technologies Enzymes Gene Expression Genetic Engineering Halozyme Hoffmann La Roche Hyaluronidase

    Related ETFs - A few ETFs which own one or more of the above listed Intrexon stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 3.44
    CSMD B Congress SMid Growth ETF 2.45
    PBE D PowerShares Dynamic Biotech & Genome 2.42
    FFND A The Future Fund Active ETF 1.44
    BBP C BioShares Biotechnology Products Fund 1.38
    View all Intrexon ETFs...
    Compare ETFs
    Compare FBT to BBP Compare FFND to BBP Compare PBE to BBP

        Intrexon Stocks Recent News

        Date Stock Title
        Nov 20 PGEN Precigen (NASDAQ:PGEN shareholders incur further losses as stock declines 13% this week, taking five-year losses to 86%
        Nov 20 HALO Halozyme: Fabless Or Not, The Stock Is Now A Steal On Evotec Deal
        Nov 19 HALO 3 Reasons Why Growth Investors Shouldn't Overlook Halozyme Therapeutics (HALO)
        Nov 19 HALO HALO vs. FOLD: Which Stock Should Value Investors Buy Now?
        Nov 19 HALO Is Halozyme Therapeutics (HALO) a Great Value Stock Right Now?
        Nov 19 HALO Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
        Nov 18 HALO Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
        Nov 17 HALO Halozyme plans to finance $2.1B takeover of Evotech in cash: report
        Nov 17 HALO Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says
        Nov 15 HALO Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer
        Nov 15 HALO Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion
        Nov 15 HALO Halozyme Submits $2.11 Billion Acquisition Offer For Evotec
        Nov 15 HALO Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid
        Nov 15 HALO Halozyme bids for Evotec; BeiGene gets a new name
        Nov 14 HALO Germany’s Evotec Gets Takeover Interest From Halozyme
        Nov 14 PGEN Precigen GAAP EPS of -$0.09 misses by $0.01, revenue of $0.95M misses by $0.33M
        Nov 14 PGEN Precigen Reports Third Quarter 2024 Financial Results and Business Updates
        Nov 14 HALO Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Life Sciences Antibodies Aquaculture Biological Engineering Biology Biopharmaceutical Cattle Clinical Trial Product Cloning Control Solutions Diabetes Diabetes Mellitus Emerging Technologies Enzymes Gene Expression Genetic Engineering Halozyme Hoffmann La Roche Hyaluronidase
        Intrexon

        Precigen, Inc (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari.
        Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.

        More about Intrexon
        Browse All Tags